EN
HI
Zydus Lifesciences share price chart
Zydus Lifesciences Share Key Metrics
Volume
3.32 L
Market Cap
115022.61 CR
LTQ@LTP
9@1119.70
ATP
1120.98
Var Margin
12.8 %
Circuit Range
1028.8-1257.4
Delivery %
57.83 %
Value
37.25 CR
ASM/GSM
No
Market Lot
1
Summary
ZYDUSLIFE stock price is ₹1119.7 as of 22 Jul, 2026. The stock intraday movement has stayed between ₹1113.00 and ₹1138.10, while Zydus Lifesciences share price 52 week high low is ₹835.50 & ₹1181.50.
In terms of trading activity, ZYDUSLIFE share price has recorded a volume of 3,32,319 shares. The Zydus Lifesciences has a market cap of ₹1006233990. The stock’s Average Traded Price (ATP) stands at ₹1120.98, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 9 @ ₹1119.70.
The Zydus Lifesciences upper circuit limit is ₹1257.40 & The Zydus Lifesciences lower circuit limit is ₹1028.80, with a Value of ₹37.25 CR. The Delivery Percentage for the day is 57.83%.
Additionally, the share currently falls under the No framework, and trades with a market lot size of ₹1.
Zydus Lifesciences Fundamentals
P/E Ratio
22.69
P/B Ratio
4.4
Div. Yield
0.09
Sector P/E
69.79
Sector P/B
3.29
Sec. Div. Yield
0.53
Zydus Lifesciences Resistance and Support
Pivot 1143.63
Resistance
First Resistance
1149.26
Second Resistance
1155.43
Third Resistance
1161.06
Support
First Support
1137.46
Second Support
1131.83
Third Support
1125.66
Zydus Lifesciences Futures & Options
Zydus Lifesciences Option Chain
View Price, OI, Greeks & More...
28JUL26
1118.10
-27.70 (2.42%)
25AUG26
1124.20
-26.60 (2.31%)
29SEP26
1128.40
-31.90 (2.75%)
ZYDUSLIFE|28JUL26 CE 1110.00
54.25
0 (0%)
ZYDUSLIFE|28JUL26 PE 1120.00
16.6
10.4 (167.74%)
Zydus Lifesciences Corporate Actions
| Date | Agenda |
|---|---|
| 2026-08-11 | Quarterly Results |
| 2026-05-19 | Audited Results |
| 2026-02-09 | Quarterly Results |
| 2025-11-06 | Quarterly Results & Fund raising |
| 2025-08-12 | Quarterly Results |
| 2025-05-20 | Audited Results & Final Dividend |
| 2025-02-05 | Quarterly Results |
| 2024-11-12 | Quarterly Results |
Zydus Lifesciences News
Zydus Lifesciences Ltd - 532321 - Board Meeting Intimation for Approval Of Unaudited Financial Results For The Quarter Ended On June 30, 2026.
Zydus Life Science board will hold a meeting on August 11, 2026, to review and approve the unaudited financial results for the first quarter of fiscal year 2027. This meeting will also address other agenda items.
Jul 20 2026 12:54:01
Zydus Lifesciences Ltd - 532321 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Zydus Lifesciences has partnered with Apollo Hospitals via an MoU to expand the availability of the Shield™ Multi-Cancer Detection (MCD) test in India. This collaboration aims to enhance early diagnosis for multiple cancer types, leveraging Guardant Health's advanced blood test technology.
Jul 03 2026 12:16:59
Read More
Zydus Lifesciences Management
| Name | Position |
|---|---|
| Dhaval N Soni | Company Secretary & Compliance Officer |
| Pankaj R Patel | Chairman |
Zydus Lifesciences Similar Stocks
Divi's Laboratories Ltd.
7268.00
-62.00 (0.85%)
Torrent Pharmaceuticals Ltd.
4982.10
-58.60 (1.16%)
Apollo Hospitals Enterprise Ltd.
8884.00
-42.50 (0.48%)
Cipla Ltd.
1406.50
-26.00 (1.82%)
Lupin Ltd.
2426.50
-88.30 (3.51%)
Max Healthcare Institute Ltd.
1082.80
-17.60 (1.60%)
Mankind Pharma Ltd.
2529.20
-50.30 (1.95%)
Dr. Reddy's Laboratories Ltd.
1193.40
-12.60 (1.04%)
Zydus Lifesciences FAQs
The Buying Price of Zydus Lifesciences share is 1119.7 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Zydus Lifesciences stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Zydus Lifesciences, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Zydus Lifesciences shares is 22.69. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Zydus Lifesciences shares is 4.4. Useful to assess the stock's value relative to its book value.
To assess Zydus Lifesciences’s valuation compare Sector P/E, P/B which are 69.79 & 3.29 with sector averages, along with growth rates and financial metrics.
The Market Cap of Zydus Lifesciences is 115022.61 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Zydus Lifesciences share price is 1181.50 & 835.50. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Zydus Lifesciences belongs to the Healthcare sector.
Open a FREE Demat Account in 5 Mins.
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
